Document ID: chunk:federal_register_of_legislation:F2022C00921:front:0:p5
Version: federal_register_of_legislation:F2022C00921
Segment Type: other
Provision Reference: 
Character Range: 11608–14744

second-hand smoke has not permanently ceased, being exposed to second-hand smoke for at least 1,000 hours before the clinical worsening of peripheral artery disease;
            Note: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary.
(26)      where exposure to second-hand smoke has permanently ceased before the clinical worsening of peripheral artery disease:
(a)          being exposed to second-hand smoke for at least 5,000 hours; or
(b)          being exposed to second-hand smoke for at least 1,000 hours, but less than 5,000 hours, and the clinical worsening of peripheral artery disease has occurred within five years of the last exposure to second-hand smoke;
             Note: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary.
(27)      having hyperhomocysteinaemia before the clinical worsening of peripheral artery disease;
(28)      an inability to undertake any physical activity greater than three METs for at least five years within the 20 years before the clinical worsening of peripheral artery disease;
            Note: MET is defined in the Schedule 1 - Dictionary.
(29)      having chronic kidney disease before the clinical worsening of peripheral artery disease;
            Note: chronic kidney disease is defined in the Schedule 1 - Dictionary.
(30)      undergoing a course of therapeutic radiation for cancer, where the affected artery was in the field of radiation, before the clinical worsening of peripheral artery disease;
(31)      having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to the affected artery before the clinical worsening of peripheral artery disease;
            Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(32)      an inability to consume an average of at least 100 grams per day of any combination of fruit and vegetables, for at least five consecutive years within the 20 years before the clinical worsening of peripheral artery disease;
(33)      having periodontitis for at least the two years before the clinical worsening of peripheral artery disease;
(34)      having an autoimmune disease before the clinical worsening of peripheral artery disease;
Note: Examples of autoimmune diseases include systemic lupus erythematosus, psoriasis and rheumatoid arthritis.
(35)      having a clinically significant depressive disorder for at least five years before the clinical worsening of peripheral artery disease;
            Note: clinically significant is defined in the Schedule 1 - Dictionary.
(36)      taking the tyrosine kinase inhibitors nilotinib or ponatinib before the clinical worsening of peripheral artery disease;
(37)      inability to obtain appropriate clinical management for peripheral artery disease.
     10           Relationship to service
(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
(2)          The factors set out in subsections 9(19) to 9(37) apply only to material contribution to, or aggravation of, peripheral artery disease